Abbott Nutrition strikes deal with FDA to restart factory linked to baby formula shortage

Shelves across US now empty of essential product

Graeme Massie
Monday 16 May 2022 19:48 EDT
Comments
Baby formula crisis

Your support helps us to tell the story

As your White House correspondent, I ask the tough questions and seek the answers that matter.

Your support enables me to be in the room, pressing for transparency and accountability. Without your contributions, we wouldn't have the resources to challenge those in power.

Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election

Head shot of Andrew Feinberg

Andrew Feinberg

White House Correspondent

The Abbott Nutrition plant linked to the shortage of baby formula has struck a deal to resume operations within two weeks, according to the US Food and Drug Administration.

Abbott entrered a consent decree with the FDA on Monday, which if court-approved sets out the steps the company needs to carry out to resume production at the Michigan factory.

It is the largest US manufacturing plant for baby formula and has been closed since February after complaints of bacterial infection in four hospitalised infants, two of whom died.

Parents are now struggling to find baby formula across the country and the shelves are empty because of a combination of product recalls, supply chain issues and labour shortages.

The company has said there is no link to its products and could re-start its production within two weeks, but that it would take “six to eight weeks” for that product to his shelves.

“Our number one priority is getting infants and families the high-quality formulas they need, and this is a major step toward re-opening our Sturgis facility so we can ease the nationwide formula shortage,” said Robert B Ford, chairman and chief executive officer of Abbott.

“We know millions of parents and caregivers depend on us and we’re deeply sorry that our voluntary recall worsened the nationwide formula shortage.”

FDA chief Dr Robert Califf said on Monday that he did not expect the shortage to last until the ened of the year.

“We don’t expect it to last until the end of the year by any means. We’re taking a number of measures including getting all the manufacturers to step up,” he said.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in